SEC 13F Intelligence

Privium Fund Management B.V. / ARQT

Privium Fund Management B.V.’s Arcutis Biotherapeutics Inc Position

Does Privium Fund Management B.V. own Arcutis Biotherapeutics Inc (ARQT)? Yes — 321.0K shares worth $8M (+1.57% of its 13F portfolio) as of Q1 2026, up from 306.0K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
321.0K
% of Portfolio
+1.57%
Quarters Held
6
currently held

Position History ARQT

Reported value by quarter
Q4 ’24: $5MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $6MQ3 ’25Q4 ’25: $9MQ4 ’25Q1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026321.0K$8M+1.57%
Q4 2025306.0K$9M+1.64%
Q3 2025306.0K$6M+1.04%
Q2 2025344.5K$5M+1.02%
Q1 2025325.7K$5M+1.33%
Q4 2024325.7K$5M+1.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of ARQT.